Opaleye Management Inc. / PCVX
Opaleye Management Inc.’s Vaxcyte Inc Position
Does Opaleye Management Inc. own Vaxcyte Inc (PCVX)? Not currently — the last reported position was 75.0K shares worth $6M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$6M
Q4 2024
Shares
75.0K
% of Portfolio
+1.07%
Quarters Held
18
position exited
Position History PCVX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2024 | 75.0K | $6M | +1.07% |
| Q3 2024 | 85.0K | $10M | +1.62% |
| Q2 2024 | 85.0K | $6M | +1.47% |
| Q1 2024 | 85.0K | $6M | +1.27% |
| Q4 2023 | 90.0K | $6M | +1.50% |
| Q3 2023 | 90.0K | $5M | +1.49% |
| Q2 2023 | 177.0K | $9M | +2.11% |
| Q1 2023 | 177.0K | $7M | +1.99% |
| Q4 2022 | 177.0K | $8M | +2.95% |
| Q3 2022 | 190.0K | $5M | +1.88% |
| Q2 2022 | 190.0K | $4M | +1.86% |
| Q1 2022 | 211.0K | $5M | +1.58% |
| Q4 2021 | 315.8K | $8M | +1.59% |
| Q3 2021 | 353.4K | $9M | +1.67% |
| Q2 2021 | 357.8K | $8M | +1.34% |
| Q1 2021 | 357.8K | $7M | +1.04% |
| Q4 2020 | 335.2K | $9M | +1.16% |
| Q3 2020 | 313.0K | $15M | +3.02% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Opaleye Management Inc.’s full portfolio or all institutional holders of PCVX.